Tirzepatide

Tirzepatide is a polypeptide hormone medication

that was approved by the Food & Drug Administration (FDA) on May 2022.

‍

Its a weight loss medication

that’s injected Subcutaneously once weekly. It works by increasing satiety and curving your appetite by making you feel full.

‍

Mounjaro is the brand name for Tirzepatide

and its currently marketed by Eli Lilly company. However, due to its excessive demand/popularity, this medication is in short supply and the average cost on a monthly basis runs at a hefty price of $1000.

‍

Due to this barrier, we offer our clients/patients

an opportunity to access this weight loss medication on a monthly subscription basis. Tirzepatide will be shipped directly to your home from a licensed compounding pharmacy in the USA.

‍

Take advantage of this opportunity by joining our plan

book a consultation and start your journey. Tirzepatide has been proven to be highly effective in losing weight!

‍